Varex Imaging Booth #H1-F10 | PerkinElmer Imaging Booth #H2-B03
National Exhibition & Convention Center, Shanghai, China
SALT LAKE CITY and SHANGHAI, May 11, 2017 /PRNewswire/ -- Varex Imaging Corporation (Nasdaq: VREX) today announced that its Varex and recently acquired PerkinElmer imaging solution lines will be exhibited at the 2017 China International Medical Equipment Fair taking place at the National Exhibition & Convention Center in Shanghai, China on May 15 - 18, 2017.
On May 1, 2017, Varex completed the acquisition of the PerkinElmer medical imaging business, which develops, manufactures and sells digital detectors that are key components in medical and industrial X-ray imaging systems made by global OEM manufacturers.
At the CMEF, the Varex and PerkinElmer X-ray imaging process solutions will be represented in both of the exhibit halls. Being highlighted via the respective exhibit booths is a range of advanced X-ray tubes and digital flat panel detectors, as well as connect and control components and imaging software.
Digital Flat Panel Detectors
X-ray Tubes
Connect & Control
Software
About Varex Imaging
Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include tubes, digital flat panel detectors and other image processing solutions, which are key components of X-ray imaging systems. With a 65+ year history of successful innovation, Varex's components are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers of X-ray imaging systems use the company's X-ray sources, digital detectors, connecting devices and imaging software as components in their systems to detect, diagnose and protect. Varex employs approximately 1,800 people, including the employees from PerkinElmer, located at manufacturing and service center sites in North America, Europe, and Asia. For more information about Varex, visit vareximaging.com.
Forward Looking Statements
Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry or market outlook; the company's recent acquisition of the PerkinElmer medical imaging business; growth drivers; customer demand and acceptance of products or technology; the ability of the company's technology and products to achieve stated results or outcomes; and any statements using the terms "will," "could," "believe," "expect," "intend," "anticipate," or similar statements are forward-looking statements that involve risks and uncertainties that could cause the company's actual results to differ materially from those anticipated. Such risks and uncertainties include the ability to effectively integrate the products of PerkinElmer's medical imaging business into the company's product offerings and sales and marketing operations, recognize the intended benefits and synergies of the acquisition, and retain the services of key acquired personnel; global economic conditions; demand for and delays in delivery of products of the company, PerkinElmer's medical imaging business or their respective customers; the company's ability to develop, commercialize and deploy new products; the impact of reduced or limited demand by purchasers of certain X-ray products; the impact of competitive products and pricing; and the other risks listed from time to time in the company's filings with the U.S. Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.
For Information Contact: |
|
Howard Goldman |
Elaine Rebele |
Director of Investor & Public Relations |
Manager of Marketing Communications |
Varex Imaging Corporation |
Varex Imaging Corporation |
+1.801.978.5274 |
+1.801.978.5715 |